Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
Efstathios S Giotis, Emine Cil, Greg N Brooke
Viruses, doi:10.3390/v14122728
, caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2), is estimated to have caused over 6.5 million deaths worldwide. The emergence of fast-evolving SARS-CoV-2 variants of concern alongside increased transmissibility and/or virulence, as well as immune and vaccine escape capabilities, highlight the urgent need for more effective antivirals to combat the disease in the long run along with regularly updated vaccine boosters. One of the early risk factors identified during the COVID-19 pandemic was that men are more likely to become infected by the virus, more likely to develop severe disease and exhibit a higher likelihood of hospitalisation and mortality rates compared to women. An association exists between SARS-CoV-2 infectiveness and disease severity with sex steroid hormones and, in particular, androgens. Several studies underlined the importance of the androgen-mediated regulation of the host protease TMPRSS2 and the cell entry protein ACE2, as well as the key role of these factors in the entry of the virus into target cells. In this context, modulating androgen signalling is a promising strategy to block viral infection, and antiandrogens could be used as a preventative measure at the pre-or early hospitalisation stage of COVID-19 disease. Different antiandrogens, including commercial drugs used to treat metastatic castration-sensitive prostate cancer and other conditions, have been tested as antivirals with varying success. In this review, we summarise the most recent updates concerning the use of antiandrogens as prophylactic and therapeutic options for COVID-19.
Conflicts of Interest: The authors declare no conflict of interest.
References
Adjei, Hong, Molinari, Bull-Otterson, Ajani et al., Mortality risk among patients hospitalized primarily for COVID-19 during the Omicron and Delta variant pandemic periods-United States, April 2020-June 2022, MMWR Morb. Mortal. Wkly. Rep,
doi:10.15585/mmwr.mm7137a4Al-Attar, Presnell, Peterson, Thomas, Lutz, The effect of sex on immune cells in healthy aging: Elderly women have more robust natural killer lymphocytes than do elderly men, Mech. Ageing Dev,
doi:10.1016/j.mad.2016.04.001Alpanes, Fernandez-Duran, Escobar-Morreale, Androgens and polycystic ovary syndrome, Expert Rev. Endocrinol. Metab,
doi:10.1586/eem.11.85Alzain, Elbadwi, Alsamani, Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies, Inform. Med. Unlocked,
doi:10.1016/j.imu.2022.100870Andrews, Tessier, Stowe, Gower, Kirsebom et al., Duration of protection against mild and severe disease by COVID-19 Vaccines, N. Engl. J. Med,
doi:10.1056/NEJMoa2115481Anestis, Zoi, Papavassiliou, Karamouzis, Androgen receptor in breast cancer-clinical and preclinical research insights, Molecules,
doi:10.3390/molecules25020358Antonelli, Penfold, Merino, Sudre, Molteni et al., Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: A prospective, community-based, nested, case-control study, Lancet Infect Dis,
doi:10.1016/S1473-3099(21)00460-6Antonelli, Pujol, Spector, Ourselin, Steves, Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2, Lancet,
doi:10.1016/S0140-6736(22)00941-2Baratchian, Mcmanus, Berk, Nakamura, Mukhopadhyay et al., Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes, Sci. Rep,
doi:10.1038/s41598-021-90491-1Bayati, Kumar, Francis, Mcpherson, SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis, J. Biol. Chem,
doi:10.1016/j.jbc.2021.100306Beigel, Tomashek, Dodd, Mehta, Zingman et al., Remdesivir for the treatment of COVID-19-Final report, N. Engl. J. Med,
doi:10.1056/NEJMoa2007764Belouzard, Millet, Licitra, Whittaker, Mechanisms of coronavirus cell entry mediated by the viral spike protein, Viruses,
doi:10.3390/v4061011Bestle, Heindl, Limburg, Van Lam Van, Pilgram et al., TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells, Life Sci. Alliance,
doi:10.26508/lsa.202000786Bleach, Mcilroy, The divergent function of androgen receptor in breast cancer; analysis of steroid mediators and tumor intracrinology, Front. Endocrinol,
doi:10.3389/fendo.2018.00594Brooke, Waxman, Bevan, The role of androgen receptor mutations in progression of prostate cancer
Calcagnile, Forgez, Iannelli, Bucci, Alifano et al., Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 spike protein, Biochimie,
doi:10.1016/j.biochi.2020.11.004Chakravarty, Nair, Hammouda, Ratnani, Gharib et al., Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer, Commun. Biol,
doi:10.1038/s42003-020-1088-9Chen, Jiang, Xia, Liu, Yu et al., Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation, Aging Cell,
doi:10.1111/acel.13168Clinckemalie, Spans, Dubois, Laurent, Helsen et al., Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element, Mol. Endocrinol,
doi:10.1210/me.2013-1098Collin, Queen, Zerti, Dorgau, Georgiou et al., Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface, Ocul. Surf,
doi:10.1016/j.jtos.2020.05.013Deng, Rasool, Russell, Natesan, Asangani, Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19, iScience,
doi:10.1016/j.isci.2021.102254Doi, Ikeda, Hayase, Moriya, Morimura et al., Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with COVID-19: A case series, Crit. Care,
doi:10.1186/s13054-020-03078-zEsumi, Ishibashi, Yamaguchi, Nakajima, Tai et al., Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection, Hepatology,
doi:10.1002/hep.27426Evans, Mcauley, Harrison, Shikotra, Singapuri et al., Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): A UK multicentre, prospective cohort study, Lancet Respir. Med,
doi:10.1016/S2213-2600(21)00383-0Feikin, Abu-Raddad, Andrews, Davies, Higdon et al., Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization, Vaccine,
doi:10.1016/j.vaccine.2022.04.069Feng, He, Androgen receptor signaling in the development of castration-resistant prostate cancer, Front. Oncol,
doi:10.3389/fonc.2019.00858Fernandez-De-Las-Penas, De-La-Llave-Rincon, Ortega-Santiago, Ambite-Quesada, Gomez-Mayordomo et al., Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: A multicenter study, Pain,
doi:10.1097/j.pain.0000000000002564Fioretti, Sita-Lumsden, Bevan, Brooke, Revising the role of the androgen receptor in breast cancer, J. Mol. Endocrinol,
doi:10.1530/JME-14-0030Fish, The X-files in immunity: Sex-based differences predispose immune responses, Nat. Rev. Immunol,
doi:10.1038/nri2394Foo, Nakagawa, Rhodes, Simmons, The effects of sex hormones on immune function: A meta-analysis, Biol. Rev. Camb. Philos. Soc,
doi:10.1111/brv.12243Gierer, Bertram, Kaup, Wrensch, Heurich et al., The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies, J. Virol,
doi:10.1128/JVI.00128-13Giotis, Carnell, Young, Ghanny, Soteropoulos et al., Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor, Nat. Microbiol,
doi:10.1038/s41564-019-0517-3Group, Horby, Lim, Emberson, Mafham et al., Dexamethasone in hospitalized patients with COVID-19, N. Engl. J. Med
Gunst, Staerke, Pahus, Kristensen, Bodilsen et al., Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with COVID-19-A double-blind randomized controlled trial, EClinicalMedicine,
doi:10.1016/j.eclinm.2021.100849Henderson, Canna, Schulert, Volpi, Lee et al., On the alert for cytokine storm: Immunopathology in COVID-19, Arthritis Rheumatol,
doi:10.1002/art.41285Hoffmann, Kleine-Weber, Schroeder, Kruger, Herrler et al., SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell,
doi:10.1016/j.cell.2020.02.052Hofmann-Winkler, Moerer, Alt-Epping, Brauer, Buttner et al., Camostat mesylate may reduce severity of coronavirus disease 2019 sepsis: A first observation, Crit. Care Explor,
doi:10.1097/CCE.0000000000000284Hu, Shrimp, Guo, Xu, Chen et al., Discovery of TMPRSS2 inhibitors from virtual screening as a potential treatment of COVID-19, ACS Pharmacol. Transl. Sci,
doi:10.1021/acsptsci.0c00221Huang, Li, Gu, Zhang, Ren et al., Health outcomes in people 2 years after surviving hospitalisation with COVID-19: A longitudinal cohort study, Lancet Respir. Med,
doi:10.1016/S2213-2600(22)00126-6Ioannidis, Axfors, Contopoulos-Ioannidis, Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters, Environ. Res,
doi:10.1016/j.envres.2020.109890Irham, Chou, Calkins, Adikusuma, Hsieh et al., Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents, Biochem. Biophys. Res. Commun,
doi:10.1016/j.bbrc.2020.05.179Iwata-Yoshikawa, Okamura, Shimizu, Hasegawa, Takeda et al., TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection, J. Virol,
doi:10.1128/JVI.01815-18Jang, Rhee, Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy, Int. J. Infect. Dis,
doi:10.1016/j.ijid.2020.05.072Jia, Neptune, Cui, Targeting ACE2 for COVID-19 Therapy: Opportunities and challenges, Am. J. Respir. Cell Mol. Biol,
doi:10.1165/rcmb.2020-0322PSJin, Bai, He, Wu, Liu et al., Gender differences in patients with COVID-19: Focus on severity and mortality, Front. Public Health,
doi:10.3389/fpubh.2020.00152Joshi, Tyagi, Nigam, Molecular Level dissection of critical spike mutations in SARS-CoV-2 variants of concern (VOCs): A simplified review, ChemistrySelect,
doi:10.1002/slct.202102074Katopodis, Kerslake, Davies, Randeva, Chatha et al., COVID-19 and SARS-CoV-2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease, Int. J. Mol. Med,
doi:10.3892/ijmm.2021.4897Khan, Ansar Ahmed, The immune System is a natural target for estrogen action: Opposing effects of estrogen in two prototypical autoimmune diseases, Front. Immunol,
doi:10.3389/fimmu.2015.00635Khoury, Docken, Subbarao, Kent, Davenport et al., Predicting the efficacy of variant-modified COVID-19 vaccine boosters, bioRxiv,
doi:10.1101/2022.08.25.22279237Klein, Hodgson, Robinson, Mechanisms of sex disparities in influenza pathogenesis, J. Leukoc. Biol,
doi:10.1189/jlb.0811427Klein, Huber, Sex differences in susceptibility to viral infection
Klein, Sex differences in prophylaxis and therapeutic treatments for viral diseases, Handb. Exp. Pharmacol
Kumar, Faiq, Pareek, Raza, Narayan et al., Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients, Med. Hypotheses,
doi:10.1016/j.mehy.2020.110271Lanz, Bennamoun, Macek, Cathelineau, Sanchez-Salas, The importance of antiandrogen in prostate cancer treatment, Ann. Transl. Med,
doi:10.21037/atm.2019.09.53Leach, Mohr, Giotis, Cil, Isac et al., The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells, Nat. Commun,
doi:10.1038/s41467-021-24342-yLee, Heberer, Gao, Becker, Loeb et al., A population-level analysis of the protective effects of androgen deprivation therapy against COVID-19 disease incidence and severity, Front. Med,
doi:10.3389/fmed.2022.774773Lee, Perl, Steiner, Pasternack, Li et al., neurovascular injury with complement activation and inflammation in COVID-19, Brain,
doi:10.1093/brain/awac151Li, Han, Dai, Xu, He et al., Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide,
doi:10.1038/s41467-021-21171-xLi, Huang, Wang, Wang, Liang et al., COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis, J. Med. Virol,
doi:10.1002/jmv.25757Liao, Huang, Xiao, Gu, Ouyang et al., Estrogen signaling effects on muscle-specific immune responses through controlling the recruitment and function of macrophages and T cells, Skelet Muscle,
doi:10.1186/s13395-019-0205-2Libert, Dejager, Pinheiro, The X chromosome in immune functions: When a chromosome makes the difference, Nat. Rev. Immunol,
doi:10.1038/nri2815Limburg, Harbig, Bestle, Stein, Moulton et al., TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes, J. Virol,
doi:10.1128/JVI.00649-19Lin, Ferguson, White, Wang, Vessella et al., Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2, Cancer Res
Long, Mistry, Haslam, Barclay, Host and viral determinants of influenza A virus species specificity, Nat. Rev. Microbiol,
doi:10.1038/s41579-018-0115-zLucas, Heinlein, Kim, Hernandez, Malik et al., The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis, Cancer Discov,
doi:10.1158/2159-8290.CD-13-1010Lukassen, Chua, Trefzer, Kahn, Schneider et al., SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells, EMBO J,
doi:10.15252/embj.2020105114Luttens, Gullberg, Abdurakhmanov, Vo, Akaberi et al., Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses, J. Am. Chem. Soc,
doi:10.1021/jacs.1c08402Mackin, Edwards, Atuk, Beltrami, Condon et al., Structure/function analysis of truncated amino-terminal ACE2 peptide analogs that bind to SARS-CoV-2 spike glycoprotein, Molecules,
doi:10.3390/molecules27072070Mahgoub, Alnaem, Fadlelmola, Abo-Idris, Makki et al., Discovery of novel potential inhibitors of TMPRSS2 and Mpro of SARS-CoV-2 using E-pharmacophore and docking-based virtual screening combined with molecular dynamic and quantum mechanics, J. Biomol. Struct. Dyn,
doi:10.1080/07391102.2022.2112080Mahoney, Damalanka, Tartell, Chung, Lourenco et al., A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells, Proc. Natl. Acad. Sci,
doi:10.1073/pnas.2108728118Manandhar, Pai, Krishnamurthy, Kiran, Kumari, Identification, virtual screening and molecular dynamic analysis of novel TMPRSS2 inhibitors from natural compound database as potential entry-blocking agents in SARS-CoV-2 therapy, Struct. Chem,
doi:10.1007/s11224-022-01991-3Matsuyama, Nagata, Shirato, Kawase, Takeda et al., Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2, J. Virol,
doi:10.1128/JVI.01542-10Mccoy, Cadegiani, Wambier, Herrera, Vano-Galvan et al., 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia, J. Eur. Acad. Dermatol. Venereol,
doi:10.1111/jdv.17021Mcmanus, Gaston, Zein, Sharifi, Association Between Asthma and Reduced Androgen Receptor Expression in Airways, J. Endocr. Soc,
doi:10.1210/jendso/bvac047Mikkonen, Pihlajamaa, Sahu, Zhang, Janne, Androgen receptor and androgen-dependent gene expression in lung, Mol. Cell Endocrinol,
doi:10.1016/j.mce.2009.12.022Montazersaheb, Hosseiniyan Khatibi, Hejazi, Tarhriz, Farjami et al., COVID-19 infection: An overview on cytokine storm and related interventions, Virol. J,
doi:10.1186/s12985-022-01814-1Monteil, Dyczynski, Lauschke, Kwon, Wirnsberger et al., Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection, EMBO Mol. Med,
doi:10.15252/emmm.202013426Montopoli, Zumerle, Vettor, Rugge, Zorzi et al., Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: A population-based study (N = 4532), Ann. Oncol,
doi:10.1016/j.annonc.2020.04.479Nickols, Mi, Dematt, Biswas, Clise et al., Effect of androgen suppression on clinical outcomes in hospitalized men with COVID-19: The HITCH randomized clinical trial, JAMA Netw. Open,
doi:10.1001/jamanetworkopen.2022.7852Patel, Zhong, Liaw, Tremblay, Tsao et al., Does androgen deprivation therapy protect against severe complications from COVID-19?, Ann. Oncol,
doi:10.1016/j.annonc.2020.06.023Peacock, Brown, Zhou, Thakur, Sukhova et al., The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein, bioRxiv,
doi:10.1101/2021.12.31.474653Punjani, Flannigan, Androgens and COVID-19: Exploring the role of testosterone replacement therapy, Int. J. Impot. Res,
doi:10.1038/s41443-021-00524-6Rahbar Saadat, Hosseiniyan Khatibi, Zununi Vahed, Ardalan, Host serine proteases: A potential targeted therapy for COVID-19 and influenza, Front. Mol. Biosci,
doi:10.3389/fmolb.2021.725528Rahman, Basharat, Yousuf, Castaldo, Rastrelli et al., Virtual screening of natural products against Type II transmembrane serine protease (TMPRSS2), the priming agent of coronavirus 2 (SARS-CoV-2), Molecules,
doi:10.3390/molecules25102271Rockx, Kuiken, Herfst, Bestebroer, Lamers et al., Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model, Science,
doi:10.1126/science.abb7314Rubin, From positive to negative to positive again-The mystery of why COVID-19 rebounds in some Patients who take paxlovid, JAMA,
doi:10.1001/jama.2022.9925Ruggieri, Gagliardi, Anticoli, Sex-dependent outcome of Hepatitis B and C viruses infections: Synergy of sex hormones and immune responses? Front, Immunol,
doi:10.3389/fimmu.2018.02302Shapira, Monreal, Dion, Buchholz, Imbiakha et al., A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic, Nature,
doi:10.1038/s41586-022-04661-wSharif-Askari, Saheb Sharif-Askari, Alabed, Temsah, Al Heialy et al., Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD, Mol. Ther. Methods Clin. Dev,
doi:10.1016/j.omtm.2020.05.013Shen, Qian, Yu, Narva, Yu et al., Inhibition of Influenza A virus propagation by benzoselenoxanthenes stabilizing TMPRSS2 Gene G-quadruplex and hence down-regulating TMPRSS2 expression, Sci. Rep,
doi:10.1038/s41598-020-64368-8Shirato, Kawase, Matsuyama, Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2, J. Virol,
doi:10.1128/JVI.01890-13Shrestha, Foster, Rawlinson, Tedla, Bull, Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission, Rev. Med. Virol,
doi:10.1002/rmv.2381Shulla, Heald-Sargent, Subramanya, Zhao, Perlman et al., A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry, J. Virol,
doi:10.1128/JVI.02062-10Singh, Choudhari, Nema, Khan, ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease, Microb. Pathog,
doi:10.1016/j.micpath.2020.104621Stopsack, Mucci, Antonarakis, Nelson, Kantoff, TMPRSS2 and COVID-19: Serendipity or opportunity for intervention?, Cancer Discov,
doi:10.1158/2159-8290.CD-20-0451Tallei, Alhumaid, Almusa, Fatimawali; Kusumawaty, Alynbiawi et al., Update on the omicron sub-variants BA.4 and BA.5, Rev. Med. Virol,
doi:10.1002/rmv.2391Tao, Tzou, Nouhin, Gupta, De Oliveira et al., The biological and clinical significance of emerging SARS-CoV-2 variants, Nat. Rev. Genet,
doi:10.1038/s41576-021-00408-xTegally, Moir, Everatt, Giovanetti, Scheepers et al., Emergence of SARS-CoV-2 omicron lineages BA.4 and BA.5 in South Africa, Nat. Med,
doi:10.1038/s41591-022-01911-2Thompson, Natarajan, Irving, Rowley, Griggs et al., Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance-VISION Network, 10 States, MMWR Morb. Mortal. Wkly. Rep
Tian, Kuo, Chen, Ou, Enhancement of hepatitis B virus replication by androgen and its receptor in mice, J. Virol,
doi:10.1128/JVI.06707-11Vangeel, Chiu, De Jonghe, Maes, Slechten et al., molnupiravir and nirmatrelvir remain active against SARS-CoV-2 omicron and other variants of concern, Antiviral Res,
doi:10.1016/j.antiviral.2022.105252Wang, Chiou, Poirion, Buchanan, Valdez et al., Single-cell multiomic profiling of human lungs reveals cell-type-specific and age-dynamic control of SARS-CoV-2 host genes, Elife,
doi:10.7554/eLife.62522Wang, Yang, Broad-spectrum prodrugs with anti-SARS-CoV-2 activities: Strategies, benefits, and challenges, J. Med. Virol,
doi:10.1002/jmv.27517Wang, Yang, Zhao, Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery, Comput. Struct. Biotechnol. J,
doi:10.1016/j.csbj.2021.08.029Weinreich, Sivapalasingam, Norton, Ali, Gao et al., REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19, N. Engl. J. Med,
doi:10.1056/NEJMoa2035002Welen, Rosendal, Gisslen, Lenman, Freyhult et al., A Phase 2 Trial of the effect of antiandrogen therapy on COVID-19 outcome: No evidence of benefit, supported by epidemiology and in vitro data, Eur. Urol,
doi:10.1016/j.eururo.2021.12.013Whitaker, Elliott, Chadeau-Hyam, Riley, Darzi et al., Persistent COVID-19 symptoms in a community study of 606,434 people in England, Nat. Commun,
doi:10.1038/s41467-022-29521-zWillett, Grove, Maclean, Wilkie, De Lorenzo et al., SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway, Nat. Rev. Immunol,
doi:10.1038/s41577-022-00681-9Williamson, Walker, Bhaskaran, Bacon, Bates et al., Factors associated with COVID-19-related death using OpenSAFELY, Nature,
doi:10.1038/s41586-020-2521-4Xu, Chen, Yuan, Yi, Ding et al., Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19), Clin. Infect Dis,
doi:10.1093/cid/ciaa351Yadav, Chaudhary, Jain, Chaudhary, Khanra et al., Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19, Cells,
doi:10.3390/cells10040821Zhang, Dong, Liu, Gao, Risk and protective factors for COVID-19 morbidity, severity, and mortality, Clin. Rev. Allergy Immunol,
doi:10.1007/s12016-022-08921-5Zhang, Penn, Barclay, Giotis, Naive human macrophages are refractory to SARS-CoV-2 infection and exhibit a modest inflammatory response early in infection, Viruses,
doi:10.3390/v14020441Zhang, Penninger, Li, Zhong, Slutsky, Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target, Intensive Care Med,
doi:10.1007/s00134-020-05985-9Zhang, Xie, Hashimoto, Current status of potential therapeutic candidates for the COVID-19 crisis, Brain Behav. Immun,
doi:10.1016/j.bbi.2020.04.046Zhu, Ji, Pang, Zhong, Li et al., Clinical characteristics of 3,062 COVID-19 patients: A meta-analysis, J. Med. Virol,
doi:10.1002/jmv.25884Zou, Chen, Zou, Han, Hao et al., Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection, Front. Med,
doi:10.1007/s11684-020-0754-0{ 'indexed': {'date-parts': [[2024, 7, 2]], 'date-time': '2024-07-02T13:18:22Z', 'timestamp': 1719926302487},
'reference-count': 151,
'publisher': 'MDPI AG',
'issue': '12',
'license': [ { 'start': { 'date-parts': [[2022, 12, 7]],
'date-time': '2022-12-07T00:00:00Z',
'timestamp': 1670371200000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0/'}],
'funder': [{'name': 'University of Essex COVID-19 Rapid'}, {'name': 'Agile Fund'}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'abstract': '<jats:p>COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2), '
'is estimated to have caused over 6.5 million deaths worldwide. The emergence of fast-evolving '
'SARS-CoV-2 variants of concern alongside increased transmissibility and/or virulence, as well '
'as immune and vaccine escape capabilities, highlight the urgent need for more effective '
'antivirals to combat the disease in the long run along with regularly updated vaccine '
'boosters. One of the early risk factors identified during the COVID-19 pandemic was that men '
'are more likely to become infected by the virus, more likely to develop severe disease and '
'exhibit a higher likelihood of hospitalisation and mortality rates compared to women. An '
'association exists between SARS-CoV-2 infectiveness and disease severity with sex steroid '
'hormones and, in particular, androgens. Several studies underlined the importance of the '
'androgen-mediated regulation of the host protease TMPRSS2 and the cell entry protein ACE2, as '
'well as the key role of these factors in the entry of the virus into target cells. In this '
'context, modulating androgen signalling is a promising strategy to block viral infection, and '
'antiandrogens could be used as a preventative measure at the pre- or early hospitalisation '
'stage of COVID-19 disease. Different antiandrogens, including commercial drugs used to treat '
'metastatic castration-sensitive prostate cancer and other conditions, have been tested as '
'antivirals with varying success. In this review, we summarise the most recent updates '
'concerning the use of antiandrogens as prophylactic and therapeutic options for '
'COVID-19.</jats:p>',
'DOI': '10.3390/v14122728',
'type': 'journal-article',
'created': {'date-parts': [[2022, 12, 7]], 'date-time': '2022-12-07T07:49:35Z', 'timestamp': 1670399375000},
'page': '2728',
'source': 'Crossref',
'is-referenced-by-count': 4,
'title': 'Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients',
'prefix': '10.3390',
'volume': '14',
'author': [ { 'ORCID': 'http://orcid.org/0000-0001-8908-7824',
'authenticated-orcid': False,
'given': 'Efstathios S.',
'family': 'Giotis',
'sequence': 'first',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-5097-1548',
'authenticated-orcid': False,
'given': 'Emine',
'family': 'Cil',
'sequence': 'additional',
'affiliation': []},
{'given': 'Greg N.', 'family': 'Brooke', 'sequence': 'additional', 'affiliation': []}],
'member': '1968',
'published-online': {'date-parts': [[2022, 12, 7]]},
'reference': [ { 'key': 'ref_1',
'doi-asserted-by': 'crossref',
'first-page': '181',
'DOI': '10.1038/s41579-018-0118-9',
'article-title': 'Origin and evolution of pathogenic coronaviruses',
'volume': '17',
'author': 'Cui',
'year': '2019',
'journal-title': 'Nat. Rev. Microbiol.'},
{ 'key': 'ref_2',
'doi-asserted-by': 'crossref',
'first-page': '1182',
'DOI': '10.15585/mmwr.mm7137a4',
'article-title': 'Mortality risk among patients hospitalized primarily for COVID-19 '
'during the Omicron and Delta variant pandemic periods-United States, '
'April 2020–June 2022',
'volume': '71',
'author': 'Adjei',
'year': '2022',
'journal-title': 'MMWR Morb. Mortal. Wkly. Rep.'},
{ 'key': 'ref_3',
'doi-asserted-by': 'crossref',
'first-page': '1902',
'DOI': '10.1002/jmv.25884',
'article-title': 'Clinical characteristics of 3,062 COVID-19 patients: A meta-analysis',
'volume': '92',
'author': 'Zhu',
'year': '2020',
'journal-title': 'J. Med. Virol.'},
{ 'key': 'ref_4',
'doi-asserted-by': 'crossref',
'first-page': '1957',
'DOI': '10.1038/s41467-022-29521-z',
'article-title': 'Persistent COVID-19 symptoms in a community study of 606,434 people in '
'England',
'volume': '13',
'author': 'Whitaker',
'year': '2022',
'journal-title': 'Nat. Commun.'},
{ 'key': 'ref_5',
'doi-asserted-by': 'crossref',
'first-page': '1275',
'DOI': '10.1016/S2213-2600(21)00383-0',
'article-title': 'Physical, cognitive, and mental health impacts of COVID-19 after '
'hospitalisation (PHOSP-COVID): A UK multicentre, prospective cohort '
'study',
'volume': '9',
'author': 'Evans',
'year': '2021',
'journal-title': 'Lancet Respir. Med.'},
{ 'key': 'ref_6',
'doi-asserted-by': 'crossref',
'unstructured': 'Zhang, Z., Penn, R., Barclay, W.S., and Giotis, E.S. (2022). Naive human '
'macrophages are refractory to SARS-CoV-2 infection and exhibit a modest '
'inflammatory response early in infection. Viruses, 14.',
'DOI': '10.3390/v14020441'},
{ 'key': 'ref_7',
'doi-asserted-by': 'crossref',
'first-page': '92',
'DOI': '10.1186/s12985-022-01814-1',
'article-title': 'COVID-19 infection: An overview on cytokine storm and related '
'interventions',
'volume': '19',
'author': 'Montazersaheb',
'year': '2022',
'journal-title': 'Virol. J.'},
{ 'key': 'ref_8',
'doi-asserted-by': 'crossref',
'first-page': '1059',
'DOI': '10.1002/art.41285',
'article-title': 'On the alert for cytokine storm: Immunopathology in COVID-19',
'volume': '72',
'author': 'Henderson',
'year': '2020',
'journal-title': 'Arthritis Rheumatol.'},
{ 'key': 'ref_9',
'doi-asserted-by': 'crossref',
'first-page': '711616',
'DOI': '10.3389/fpubh.2021.711616',
'article-title': 'COVID-19: Pulmonary and extra pulmonary manifestations',
'volume': '9',
'author': 'Elrobaa',
'year': '2021',
'journal-title': 'Front. Public Health'},
{ 'key': 'ref_10',
'doi-asserted-by': 'crossref',
'first-page': '2555',
'DOI': '10.1093/brain/awac151',
'article-title': 'neurovascular injury with complement activation and inflammation in '
'COVID-19',
'volume': '145',
'author': 'Lee',
'year': '2022',
'journal-title': 'Brain'},
{ 'key': 'ref_11',
'doi-asserted-by': 'crossref',
'first-page': 'e072117',
'DOI': '10.1136/bmj-2022-072117',
'article-title': 'Long COVID-an update for primary care',
'volume': '378',
'author': 'Greenhalgh',
'year': '2022',
'journal-title': 'BMJ'},
{ 'key': 'ref_12',
'doi-asserted-by': 'crossref',
'first-page': '411',
'DOI': '10.1016/S0140-6736(22)01385-X',
'article-title': 'Long COVID: Which symptoms can be attributed to SARS-CoV-2 infection?',
'volume': '400',
'author': 'Brightling',
'year': '2022',
'journal-title': 'Lancet'},
{ 'key': 'ref_13',
'doi-asserted-by': 'crossref',
'first-page': '863',
'DOI': '10.1016/S2213-2600(22)00126-6',
'article-title': 'Health outcomes in people 2 years after surviving hospitalisation with '
'COVID-19: A longitudinal cohort study',
'volume': '10',
'author': 'Huang',
'year': '2022',
'journal-title': 'Lancet Respir. Med.'},
{ 'key': 'ref_14',
'doi-asserted-by': 'crossref',
'first-page': '908757',
'DOI': '10.3389/fpubh.2022.908757',
'article-title': 'Post-acute sequelae of SARS-CoV-2 infection: A neglected public health '
'issue',
'volume': '10',
'author': 'Wang',
'year': '2022',
'journal-title': 'Front. Public Health'},
{ 'key': 'ref_15',
'doi-asserted-by': 'crossref',
'first-page': '3516',
'DOI': '10.1016/j.vaccine.2022.04.069',
'article-title': 'Assessing vaccine effectiveness against severe COVID-19 disease caused '
'by omicron variant. Report from a meeting of the World Health '
'Organization',
'volume': '40',
'author': 'Feikin',
'year': '2022',
'journal-title': 'Vaccine'},
{ 'key': 'ref_16',
'doi-asserted-by': 'crossref',
'first-page': '340',
'DOI': '10.1056/NEJMoa2115481',
'article-title': 'Duration of protection against mild and severe disease by COVID-19 '
'Vaccines',
'volume': '386',
'author': 'Andrews',
'year': '2022',
'journal-title': 'N. Engl. J. Med.'},
{ 'key': 'ref_17',
'doi-asserted-by': 'crossref',
'first-page': 'e2381',
'DOI': '10.1002/rmv.2381',
'article-title': 'Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications '
'for immune escape and transmission',
'volume': '32',
'author': 'Shrestha',
'year': '2022',
'journal-title': 'Rev. Med. Virol.'},
{ 'key': 'ref_18',
'doi-asserted-by': 'crossref',
'first-page': '7981',
'DOI': '10.1002/slct.202102074',
'article-title': 'Molecular Level dissection of critical spike mutations in SARS-CoV-2 '
'variants of concern (VOCs): A simplified review',
'volume': '6',
'author': 'Joshi',
'year': '2021',
'journal-title': 'ChemistrySelect'},
{ 'key': 'ref_19',
'doi-asserted-by': 'crossref',
'first-page': '757',
'DOI': '10.1038/s41576-021-00408-x',
'article-title': 'The biological and clinical significance of emerging SARS-CoV-2 '
'variants',
'volume': '22',
'author': 'Tao',
'year': '2021',
'journal-title': 'Nat. Rev. Genet.'},
{ 'key': 'ref_20',
'doi-asserted-by': 'crossref',
'first-page': '508',
'DOI': '10.1016/j.chom.2021.02.020',
'article-title': 'The variant gambit: COVID-19’s next move',
'volume': '29',
'author': 'Plante',
'year': '2021',
'journal-title': 'Cell Host Microbe'},
{ 'key': 'ref_21',
'doi-asserted-by': 'crossref',
'first-page': '1785',
'DOI': '10.1038/s41591-022-01911-2',
'article-title': 'Emergence of SARS-CoV-2 omicron lineages BA.4 and BA.5 in South Africa',
'volume': '28',
'author': 'Tegally',
'year': '2022',
'journal-title': 'Nat. Med.'},
{ 'key': 'ref_22',
'first-page': 'e2391',
'article-title': 'Update on the omicron sub-variants BA.4 and BA.5',
'volume': '26',
'author': 'Tallei',
'year': '2022',
'journal-title': 'Rev. Med. Virol.'},
{ 'key': 'ref_23',
'doi-asserted-by': 'crossref',
'first-page': '139',
'DOI': '10.15585/mmwr.mm7104e3',
'article-title': 'Effectiveness of a third dose of mRNA vaccines against '
'COVID-19-associated emergency department and urgent care encounters and '
'hospitalizations among adults during periods of Delta and Omicron '
'variant predominance-VISION Network, 10 States, August 2021–January '
'2022',
'volume': '71',
'author': 'Thompson',
'year': '2022',
'journal-title': 'MMWR Morb. Mortal. Wkly. Rep.'},
{ 'key': 'ref_24',
'doi-asserted-by': 'crossref',
'unstructured': 'Khoury, D.S., Docken, S.S., Subbarao, K., Kent, S.J., Davenport, M.P., '
'and Cromer, D. (2022). Predicting the efficacy of variant-modified '
'COVID-19 vaccine boosters. bioRxiv.',
'DOI': '10.1101/2022.08.25.22279237'},
{ 'key': 'ref_25',
'doi-asserted-by': 'crossref',
'first-page': '238',
'DOI': '10.1056/NEJMoa2035002',
'article-title': 'REGN-COV2, a neutralizing antibody cocktail, in outpatients with '
'Covid-19',
'volume': '384',
'author': 'Weinreich',
'year': '2021',
'journal-title': 'N. Engl. J. Med.'},
{ 'key': 'ref_26',
'doi-asserted-by': 'crossref',
'first-page': '693',
'DOI': '10.1056/NEJMoa2021436',
'article-title': 'Dexamethasone in hospitalized patients with COVID-19',
'volume': '384',
'author': 'Group',
'year': '2021',
'journal-title': 'N. Engl. J. Med.'},
{ 'key': 'ref_27',
'doi-asserted-by': 'crossref',
'first-page': '1813',
'DOI': '10.1056/NEJMoa2007764',
'article-title': 'Remdesivir for the treatment of COVID-19-Final report',
'volume': '383',
'author': 'Beigel',
'year': '2020',
'journal-title': 'N. Engl. J. Med.'},
{ 'key': 'ref_28',
'doi-asserted-by': 'crossref',
'first-page': '105252',
'DOI': '10.1016/j.antiviral.2022.105252',
'article-title': 'Remdesivir, molnupiravir and nirmatrelvir remain active against '
'SARS-CoV-2 omicron and other variants of concern',
'volume': '198',
'author': 'Vangeel',
'year': '2022',
'journal-title': 'Antiviral Res.'},
{ 'key': 'ref_29',
'doi-asserted-by': 'crossref',
'unstructured': 'WHO Solidarity Trial Consortium (2022). Remdesivir and three other drugs '
'for hospitalised patients with COVID-19: Final results of the WHO '
'Solidarity randomised trial and updated meta-analyses. Lancet, 399, '
'1941–1953.',
'DOI': '10.1016/S0140-6736(22)00519-0'},
{ 'key': 'ref_30',
'doi-asserted-by': 'crossref',
'unstructured': 'Wang, L., Berger, N.A., Davis, P.B., Kaelber, D.C., Volkow, N.D., and '
'Xu, R. (2022). COVID-19 rebound after paxlovid and molnupiravir during '
'January–June 2022. medRxiv.',
'DOI': '10.1101/2022.06.21.22276724'},
{ 'key': 'ref_31',
'doi-asserted-by': 'crossref',
'first-page': '2380',
'DOI': '10.1001/jama.2022.9925',
'article-title': 'From positive to negative to positive again-The mystery of why COVID-19 '
'rebounds in some Patients who take paxlovid',
'volume': '327',
'author': 'Rubin',
'year': '2022',
'journal-title': 'JAMA'},
{ 'key': 'ref_32',
'doi-asserted-by': 'crossref',
'first-page': '577',
'DOI': '10.1002/jmv.25757',
'article-title': 'COVID-19 patients’ clinical characteristics, discharge rate, and '
'fatality rate of meta-analysis',
'volume': '92',
'author': 'Li',
'year': '2020',
'journal-title': 'J. Med. Virol.'},
{ 'key': 'ref_33',
'doi-asserted-by': 'crossref',
'first-page': '109890',
'DOI': '10.1016/j.envres.2020.109890',
'article-title': 'Population-level COVID-19 mortality risk for non-elderly individuals '
'overall and for non-elderly individuals without underlying diseases in '
'pandemic epicenters',
'volume': '188',
'author': 'Ioannidis',
'year': '2020',
'journal-title': 'Environ. Res.'},
{ 'key': 'ref_34',
'doi-asserted-by': 'crossref',
'first-page': '430',
'DOI': '10.1038/s41586-020-2521-4',
'article-title': 'Factors associated with COVID-19-related death using OpenSAFELY',
'volume': '584',
'author': 'Williamson',
'year': '2020',
'journal-title': 'Nature'},
{ 'key': 'ref_35',
'doi-asserted-by': 'crossref',
'first-page': '1268',
'DOI': '10.1056/NEJMe2002387',
'article-title': 'Covid-19-Navigating the uncharted',
'volume': '382',
'author': 'Fauci',
'year': '2020',
'journal-title': 'N. Engl. J. Med.'},
{ 'key': 'ref_36',
'first-page': '1',
'article-title': 'Risk and protective factors for COVID-19 morbidity, severity, and '
'mortality',
'volume': '19',
'author': 'Zhang',
'year': '2022',
'journal-title': 'Clin. Rev. Allergy Immunol.'},
{ 'key': 'ref_37',
'doi-asserted-by': 'crossref',
'first-page': '2263',
'DOI': '10.1016/S0140-6736(22)00941-2',
'article-title': 'Risk of long COVID associated with delta versus omicron variants of '
'SARS-CoV-2',
'volume': '399',
'author': 'Antonelli',
'year': '2022',
'journal-title': 'Lancet'},
{ 'key': 'ref_38',
'doi-asserted-by': 'crossref',
'first-page': '43',
'DOI': '10.1016/S1473-3099(21)00460-6',
'article-title': 'Risk factors and disease profile of post-vaccination SARS-CoV-2 '
'infection in UK users of the COVID Symptom Study app: A prospective, '
'community-based, nested, case-control study',
'volume': '22',
'author': 'Antonelli',
'year': '2022',
'journal-title': 'Lancet Infect Dis.'},
{ 'key': 'ref_39',
'doi-asserted-by': 'crossref',
'first-page': 'e989',
'DOI': '10.1097/j.pain.0000000000002564',
'article-title': 'Prevalence and risk factors of musculoskeletal pain symptoms as '
'long-term post-COVID sequelae in hospitalized COVID-19 survivors: A '
'multicenter study',
'volume': '163',
'author': 'Cuadrado',
'year': '2022',
'journal-title': 'Pain'},
{ 'key': 'ref_40',
'doi-asserted-by': 'crossref',
'first-page': '846',
'DOI': '10.1016/S0140-6736(20)30526-2',
'article-title': 'COVID-19: The gendered impacts of the outbreak',
'volume': '395',
'author': 'Wenham',
'year': '2020',
'journal-title': 'Lancet'},
{ 'key': 'ref_41',
'doi-asserted-by': 'crossref',
'first-page': '1950',
'DOI': '10.1016/j.jsxm.2021.09.003',
'article-title': 'The role of sex hormones in the disparity of COVID-19 outcomes based on '
'gender',
'volume': '18',
'author': 'Stasi',
'year': '2021',
'journal-title': 'J. Sex Med.'},
{ 'key': 'ref_42',
'doi-asserted-by': 'crossref',
'first-page': '152',
'DOI': '10.3389/fpubh.2020.00152',
'article-title': 'Gender differences in patients with COVID-19: Focus on severity and '
'mortality',
'volume': '8',
'author': 'Jin',
'year': '2020',
'journal-title': 'Front. Public Health'},
{ 'key': 'ref_43',
'doi-asserted-by': 'crossref',
'first-page': '799',
'DOI': '10.1093/cid/ciaa351',
'article-title': 'Factors associated with prolonged viral RNA shedding in patients with '
'coronavirus disease 2019 (COVID-19)',
'volume': '71',
'author': 'Xu',
'year': '2020',
'journal-title': 'Clin. Infect Dis.'},
{ 'key': 'ref_44',
'doi-asserted-by': 'crossref',
'first-page': '374',
'DOI': '10.1038/s42003-020-1088-9',
'article-title': 'Sex differences in SARS-CoV-2 infection rates and the potential link to '
'prostate cancer',
'volume': '3',
'author': 'Chakravarty',
'year': '2020',
'journal-title': 'Commun. Biol.'},
{ 'key': 'ref_45',
'doi-asserted-by': 'crossref',
'unstructured': 'Klein, S.L., and Roberts, C. (2010). Sex Hormones and Immunity to '
'Infection, Springer.',
'DOI': '10.1007/978-3-642-02155-8'},
{ 'key': 'ref_46',
'doi-asserted-by': 'crossref',
'first-page': '67',
'DOI': '10.1189/jlb.0811427',
'article-title': 'Mechanisms of sex disparities in influenza pathogenesis',
'volume': '92',
'author': 'Klein',
'year': '2012',
'journal-title': 'J. Leukoc. Biol.'},
{ 'key': 'ref_47',
'doi-asserted-by': 'crossref',
'unstructured': 'Klein, S.L. (2012). Sex differences in prophylaxis and therapeutic '
'treatments for viral diseases. Handb. Exp. Pharmacol., 499–522.',
'DOI': '10.1007/978-3-642-30726-3_22'},
{ 'key': 'ref_48',
'doi-asserted-by': 'crossref',
'first-page': '626',
'DOI': '10.1038/nri.2016.90',
'article-title': 'Sex differences in immune responses',
'volume': '16',
'author': 'Klein',
'year': '2016',
'journal-title': 'Nat. Rev. Immunol.'},
{ 'key': 'ref_49',
'doi-asserted-by': 'crossref',
'first-page': '20',
'DOI': '10.1186/s13395-019-0205-2',
'article-title': 'Estrogen signaling effects on muscle-specific immune responses through '
'controlling the recruitment and function of macrophages and T cells',
'volume': '9',
'author': 'Liao',
'year': '2019',
'journal-title': 'Skelet Muscle'},
{ 'key': 'ref_50',
'doi-asserted-by': 'crossref',
'first-page': '25',
'DOI': '10.1016/j.mad.2016.04.001',
'article-title': 'The effect of sex on immune cells in healthy aging: Elderly women have '
'more robust natural killer lymphocytes than do elderly men',
'volume': '156',
'author': 'Presnell',
'year': '2016',
'journal-title': 'Mech. Ageing Dev.'},
{ 'key': 'ref_51',
'doi-asserted-by': 'crossref',
'first-page': '737',
'DOI': '10.1038/nri2394',
'article-title': 'The X-files in immunity: Sex-based differences predispose immune '
'responses',
'volume': '8',
'author': 'Fish',
'year': '2008',
'journal-title': 'Nat. Rev. Immunol.'},
{ 'key': 'ref_52',
'doi-asserted-by': 'crossref',
'first-page': '594',
'DOI': '10.1038/nri2815',
'article-title': 'The X chromosome in immune functions: When a chromosome makes the '
'difference',
'volume': '10',
'author': 'Libert',
'year': '2010',
'journal-title': 'Nat. Rev. Immunol.'},
{ 'key': 'ref_53',
'doi-asserted-by': 'crossref',
'unstructured': 'vom Steeg, L.G., and Klein, S.L. (2016). Sex matters in infectious '
'disease pathogenesis. PLoS Pathog., 12.',
'DOI': '10.1371/journal.ppat.1005374'},
{ 'key': 'ref_54',
'doi-asserted-by': 'crossref',
'first-page': 'A479',
'DOI': '10.1016/j.autrev.2011.11.022',
'article-title': 'The influence of sex and gender on the immune response',
'volume': '11',
'year': '2012',
'journal-title': 'Autoimmun. Rev.'},
{ 'key': 'ref_55',
'doi-asserted-by': 'crossref',
'first-page': '521',
'DOI': '10.1210/er.2007-0001',
'article-title': 'The complex role of estrogens in inflammation',
'volume': '28',
'author': 'Straub',
'year': '2007',
'journal-title': 'Endocr. Rev.'},
{ 'key': 'ref_56',
'doi-asserted-by': 'crossref',
'first-page': '105',
'DOI': '10.1016/j.jsbmb.2009.12.015',
'article-title': 'Sex steroids as inflammatory regulators',
'volume': '120',
'author': 'Gilliver',
'year': '2010',
'journal-title': 'J. Steroid. Biochem. Mol. Biol.'},
{ 'key': 'ref_57',
'first-page': '635',
'article-title': 'The immune System is a natural target for estrogen action: Opposing '
'effects of estrogen in two prototypical autoimmune diseases',
'volume': '6',
'author': 'Khan',
'year': '2015',
'journal-title': 'Front. Immunol.'},
{ 'key': 'ref_58',
'doi-asserted-by': 'crossref',
'first-page': '551',
'DOI': '10.1111/brv.12243',
'article-title': 'The effects of sex hormones on immune function: A meta-analysis',
'volume': '92',
'author': 'Foo',
'year': '2017',
'journal-title': 'Biol. Rev. Camb. Philos. Soc.'},
{ 'key': 'ref_59',
'doi-asserted-by': 'crossref',
'first-page': '1931',
'DOI': '10.3389/fimmu.2018.01931',
'article-title': 'Sex hormones determine immune response',
'volume': '9',
'author': 'Taneja',
'year': '2018',
'journal-title': 'Front. Immunol.'},
{ 'key': 'ref_60',
'doi-asserted-by': 'crossref',
'first-page': '411',
'DOI': '10.1093/humupd/dmi008',
'article-title': 'Sex hormones and the immune response in humans',
'volume': '11',
'author': 'Bouman',
'year': '2005',
'journal-title': 'Hum. Reprod. Update'},
{ 'key': 'ref_61',
'doi-asserted-by': 'crossref',
'first-page': '2302',
'DOI': '10.3389/fimmu.2018.02302',
'article-title': 'Sex-dependent outcome of Hepatitis B and C viruses infections: Synergy '
'of sex hormones and immune responses?',
'volume': '9',
'author': 'Ruggieri',
'year': '2018',
'journal-title': 'Front. Immunol.'},
{ 'key': 'ref_62',
'doi-asserted-by': 'crossref',
'first-page': '1904',
'DOI': '10.1128/JVI.06707-11',
'article-title': 'Enhancement of hepatitis B virus replication by androgen and its '
'receptor in mice',
'volume': '86',
'author': 'Tian',
'year': '2012',
'journal-title': 'J. Virol.'},
{ 'key': 'ref_63',
'doi-asserted-by': 'crossref',
'first-page': '3',
'DOI': '10.1038/s41580-021-00418-x',
'article-title': 'Mechanisms of SARS-CoV-2 entry into cells',
'volume': '23',
'author': 'Jackson',
'year': '2022',
'journal-title': 'Nat. Rev. Mol. Cell Biol.'},
{ 'key': 'ref_64',
'doi-asserted-by': 'crossref',
'unstructured': 'Yadav, R., Chaudhary, J.K., Jain, N., Chaudhary, P.K., Khanra, S., '
'Dhamija, P., Sharma, A., Kumar, A., and Handu, S. (2021). Role of '
'structural and non-structural proteins and therapeutic targets of '
'SARS-CoV-2 for COVID-19. Cells, 10.',
'DOI': '10.3390/cells10040821'},
{ 'key': 'ref_65',
'doi-asserted-by': 'crossref',
'first-page': '100306',
'DOI': '10.1016/j.jbc.2021.100306',
'article-title': 'SARS-CoV-2 infects cells after viral entry via clathrin-mediated '
'endocytosis',
'volume': '296',
'author': 'Bayati',
'year': '2021',
'journal-title': 'J. Biol. Chem.'},
{ 'key': 'ref_66',
'doi-asserted-by': 'crossref',
'first-page': '11727',
'DOI': '10.1073/pnas.2003138117',
'article-title': 'Cell entry mechanisms of SARS-CoV-2',
'volume': '117',
'author': 'Shang',
'year': '2020',
'journal-title': 'Proc. Natl. Acad. Sci. USA'},
{ 'key': 'ref_67',
'doi-asserted-by': 'crossref',
'first-page': '271',
'DOI': '10.1016/j.cell.2020.02.052',
'article-title': 'SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a '
'clinically proven protease inhibitor',
'volume': '181',
'author': 'Hoffmann',
'year': '2020',
'journal-title': 'Cell'},
{ 'key': 'ref_68',
'doi-asserted-by': 'crossref',
'first-page': '239',
'DOI': '10.1097/SHK.0000000000000633',
'article-title': 'Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung '
'disease',
'volume': '46',
'author': 'Jia',
'year': '2016',
'journal-title': 'Shock'},
{ 'key': 'ref_69',
'doi-asserted-by': 'crossref',
'first-page': '2035',
'DOI': '10.1038/s41564-019-0517-3',
'article-title': 'Entry of the bat influenza H17N10 virus into mammalian cells is enabled '
'by the MHC class II HLA-DR receptor',
'volume': '4',
'author': 'Giotis',
'year': '2019',
'journal-title': 'Nat. Microbiol.'},
{ 'key': 'ref_70',
'doi-asserted-by': 'crossref',
'first-page': '67',
'DOI': '10.1038/s41579-018-0115-z',
'article-title': 'Host and viral determinants of influenza A virus species specificity',
'volume': '17',
'author': 'Long',
'year': '2019',
'journal-title': 'Nat. Rev. Microbiol.'},
{ 'key': 'ref_71',
'doi-asserted-by': 'crossref',
'first-page': '12658',
'DOI': '10.1128/JVI.01542-10',
'article-title': 'Efficient activation of the severe acute respiratory syndrome '
'coronavirus spike protein by the transmembrane protease TMPRSS2',
'volume': '84',
'author': 'Matsuyama',
'year': '2010',
'journal-title': 'J. Virol.'},
{ 'key': 'ref_72',
'doi-asserted-by': 'crossref',
'first-page': '873',
'DOI': '10.1128/JVI.02062-10',
'article-title': 'A transmembrane serine protease is linked to the severe acute '
'respiratory syndrome coronavirus receptor and activates virus entry',
'volume': '85',
'author': 'Shulla',
'year': '2011',
'journal-title': 'J. Virol.'},
{ 'key': 'ref_73',
'doi-asserted-by': 'crossref',
'first-page': '1011',
'DOI': '10.3390/v4061011',
'article-title': 'Mechanisms of coronavirus cell entry mediated by the viral spike '
'protein',
'volume': '4',
'author': 'Belouzard',
'year': '2012',
'journal-title': 'Viruses'},
{ 'key': 'ref_74',
'doi-asserted-by': 'crossref',
'first-page': '554',
'DOI': '10.1016/j.jinf.2020.02.026',
'article-title': 'COVID-19 spike-host cell receptor GRP78 binding site prediction',
'volume': '80',
'author': 'Ibrahim',
'year': '2020',
'journal-title': 'J. Infect.'},
{ 'key': 'ref_75',
'first-page': '4180',
'article-title': 'Prostate-localized and androgen-regulated expression of the '
'membrane-bound serine protease TMPRSS2',
'volume': '59',
'author': 'Lin',
'year': '1999',
'journal-title': 'Cancer Res.'},
{ 'key': 'ref_76',
'doi-asserted-by': 'crossref',
'first-page': '1310',
'DOI': '10.1158/2159-8290.CD-13-1010',
'article-title': 'The androgen-regulated protease TMPRSS2 activates a proteolytic cascade '
'involving components of the tumor microenvironment and promotes '
'prostate cancer metastasis',
'volume': '4',
'author': 'Lucas',
'year': '2014',
'journal-title': 'Cancer Discov.'},
{ 'key': 'ref_77',
'doi-asserted-by': 'crossref',
'first-page': '64',
'DOI': '10.3892/ijmm.2021.4897',
'article-title': 'COVID-19 and SARS-CoV-2 host cell entry mediators: Expression profiling '
'of TMRSS4 in health and disease',
'volume': '47',
'author': 'Katopodis',
'year': '2021',
'journal-title': 'Int. J. Mol. Med.'},
{ 'key': 'ref_78',
'doi-asserted-by': 'crossref',
'first-page': 'e105114',
'DOI': '10.15252/embj.2020105114',
'article-title': 'SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in '
'bronchial transient secretory cells',
'volume': '39',
'author': 'Lukassen',
'year': '2020',
'journal-title': 'EMBO J.'},
{ 'key': 'ref_79',
'doi-asserted-by': 'crossref',
'first-page': '110271',
'DOI': '10.1016/j.mehy.2020.110271',
'article-title': 'Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in '
'gastrointestinal tissue with pathogenesis of digestive symptoms, '
'diabetes-associated mortality, and disease recurrence in COVID-19 '
'patients',
'volume': '144',
'author': 'Kumar',
'year': '2020',
'journal-title': 'Med. Hypotheses'},
{ 'key': 'ref_80',
'doi-asserted-by': 'crossref',
'first-page': '190',
'DOI': '10.1016/j.jtos.2020.05.013',
'article-title': 'Co-expression of SARS-CoV-2 entry genes in the superficial adult human '
'conjunctival, limbal and corneal epithelium suggests an additional '
'route of entry via the ocular surface',
'volume': '19',
'author': 'Collin',
'year': '2021',
'journal-title': 'Ocul. Surf.'},
{ 'key': 'ref_81',
'doi-asserted-by': 'crossref',
'first-page': '185',
'DOI': '10.1007/s11684-020-0754-0',
'article-title': 'Single-cell RNA-seq data analysis on the receptor ACE2 expression '
'reveals the potential risk of different human organs vulnerable to '
'2019-nCoV infection',
'volume': '14',
'author': 'Zou',
'year': '2020',
'journal-title': 'Front. Med.'},
{ 'key': 'ref_82',
'doi-asserted-by': 'crossref',
'first-page': '134',
'DOI': '10.1002/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T',
'article-title': 'Expression of transmembrane serine protease TMPRSS2 in mouse and human '
'tissues',
'volume': '193',
'author': 'Vaarala',
'year': '2001',
'journal-title': 'J. Pathol.'},
{ 'key': 'ref_83',
'doi-asserted-by': 'crossref',
'first-page': '525',
'DOI': '10.1016/j.physbeh.2010.03.018',
'article-title': 'The renin angiotensin system and the metabolic syndrome',
'volume': '100',
'author': 'Krause',
'year': '2010',
'journal-title': 'Physiol. Behav.'},
{ 'key': 'ref_84',
'doi-asserted-by': 'crossref',
'first-page': '317',
'DOI': '10.3389/fcimb.2020.00317',
'article-title': 'ACE2, much more than just a receptor for SARS-COV-2',
'volume': '10',
'author': 'Samavati',
'year': '2020',
'journal-title': 'Front. Cell Infect. Microbiol.'},
{ 'key': 'ref_85',
'doi-asserted-by': 'crossref',
'first-page': '7635',
'DOI': '10.1038/s41598-020-64368-8',
'article-title': 'Inhibition of Influenza A virus propagation by benzoselenoxanthenes '
'stabilizing TMPRSS2 Gene G-quadruplex and hence down-regulating TMPRSS2 '
'expression',
'volume': '10',
'author': 'Shen',
'year': '2020',
'journal-title': 'Sci. Rep.'},
{ 'key': 'ref_86',
'doi-asserted-by': 'crossref',
'first-page': '437',
'DOI': '10.1002/hep.27426',
'article-title': 'Transmembrane serine protease TMPRSS2 activates hepatitis C virus '
'infection',
'volume': '61',
'author': 'Esumi',
'year': '2015',
'journal-title': 'Hepatology'},
{ 'key': 'ref_87',
'doi-asserted-by': 'crossref',
'first-page': '12552',
'DOI': '10.1128/JVI.01890-13',
'article-title': 'Middle East respiratory syndrome coronavirus infection mediated by the '
'transmembrane serine protease TMPRSS2',
'volume': '87',
'author': 'Shirato',
'year': '2013',
'journal-title': 'J. Virol.'},
{ 'key': 'ref_88',
'doi-asserted-by': 'crossref',
'first-page': '5502',
'DOI': '10.1128/JVI.00128-13',
'article-title': 'The spike protein of the emerging betacoronavirus EMC uses a novel '
'coronavirus receptor for entry, can be activated by TMPRSS2, and is '
'targeted by neutralizing antibodies',
'volume': '87',
'author': 'Gierer',
'year': '2013',
'journal-title': 'J. Virol.'},
{ 'key': 'ref_89',
'doi-asserted-by': 'crossref',
'first-page': 'e00649-19',
'DOI': '10.1128/JVI.00649-19',
'article-title': 'TMPRSS2 is the major activating protease of influenza A virus in '
'primary human airway cells and influenza B virus in human type II '
'pneumocytes',
'volume': '93',
'author': 'Limburg',
'year': '2019',
'journal-title': 'J. Virol.'},
{ 'key': 'ref_90',
'doi-asserted-by': 'crossref',
'first-page': 'e01815-18',
'DOI': '10.1128/JVI.01815-18',
'article-title': 'TMPRSS2 contributes to virus spread and immunopathology in the airways '
'of murine models after coronavirus infection',
'volume': '93',
'author': 'Okamura',
'year': '2019',
'journal-title': 'J. Virol.'},
{ 'key': 'ref_91',
'doi-asserted-by': 'crossref',
'first-page': 'e13168',
'DOI': '10.1111/acel.13168',
'article-title': 'Individual variation of the SARS-CoV-2 receptor ACE2 gene expression '
'and regulation',
'volume': '19',
'author': 'Chen',
'year': '2020',
'journal-title': 'Aging Cell'},
{ 'key': 'ref_92',
'doi-asserted-by': 'crossref',
'first-page': '104621',
'DOI': '10.1016/j.micpath.2020.104621',
'article-title': 'ACE2 and TMPRSS2 polymorphisms in various diseases with special '
'reference to its impact on COVID-19 disease',
'volume': '150',
'author': 'Singh',
'year': '2021',
'journal-title': 'Microb. Pathog.'},
{ 'key': 'ref_93',
'doi-asserted-by': 'crossref',
'first-page': '143',
'DOI': '10.1016/j.biochi.2020.11.004',
'article-title': 'Molecular docking simulation reveals ACE2 polymorphisms that may '
'increase the affinity of ACE2 with the SARS-CoV-2 spike protein',
'volume': '180',
'author': 'Calcagnile',
'year': '2021',
'journal-title': 'Biochimie'},
{ 'key': 'ref_94',
'doi-asserted-by': 'crossref',
'first-page': '263',
'DOI': '10.1016/j.bbrc.2020.05.179',
'article-title': 'Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression '
'among population cohorts from multiple continents',
'volume': '529',
'author': 'Irham',
'year': '2020',
'journal-title': 'Biochem. Biophys. Res. Commun.'},
{ 'key': 'ref_95',
'doi-asserted-by': 'crossref',
'first-page': '1',
'DOI': '10.1016/j.omtm.2020.05.013',
'article-title': 'Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower '
'in children than adults and increases with smoking and COPD',
'volume': '18',
'author': 'Alabed',
'year': '2020',
'journal-title': 'Mol. Ther. Methods Clin. Dev.'},
{ 'key': 'ref_96',
'doi-asserted-by': 'crossref',
'first-page': 'e62522',
'DOI': '10.7554/eLife.62522',
'article-title': 'Single-cell multiomic profiling of human lungs reveals '
'cell-type-specific and age-dynamic control of SARS-CoV-2 host genes',
'volume': '9',
'author': 'Wang',
'year': '2020',
'journal-title': 'Elife'},
{ 'key': 'ref_97',
'doi-asserted-by': 'crossref',
'first-page': '4684',
'DOI': '10.1016/j.csbj.2021.08.029',
'article-title': 'Co-crystallization and structure determination: An effective direction '
'for anti-SARS-CoV-2 drug discovery',
'volume': '19',
'author': 'Wang',
'year': '2021',
'journal-title': 'Comput. Struct. Biotechnol. J.'},
{ 'key': 'ref_98',
'doi-asserted-by': 'crossref',
'unstructured': 'Mackin, R.T., Edwards, J.V., Atuk, E.B., Beltrami, N., Condon, B.D., '
'Jayawickramarajah, J., and French, A.D. (2022). Structure/function '
'analysis of truncated amino-terminal ACE2 peptide analogs that bind to '
'SARS-CoV-2 spike glycoprotein. Molecules, 27.',
'DOI': '10.3390/molecules27072070'},
{ 'key': 'ref_99',
'doi-asserted-by': 'crossref',
'first-page': 'e13426',
'DOI': '10.15252/emmm.202013426',
'article-title': 'Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 '
'infection',
'volume': '13',
'author': 'Monteil',
'year': '2021',
'journal-title': 'EMBO Mol. Med.'},
{ 'key': 'ref_100',
'doi-asserted-by': 'crossref',
'first-page': '416',
'DOI': '10.1165/rcmb.2020-0322PS',
'article-title': 'Targeting ACE2 for COVID-19 Therapy: Opportunities and challenges',
'volume': '64',
'author': 'Jia',
'year': '2021',
'journal-title': 'Am. J. Respir. Cell Mol. Biol.'},
{ 'key': 'ref_101',
'doi-asserted-by': 'crossref',
'first-page': '36',
'DOI': '10.1016/j.metabol.2019.03.006',
'article-title': 'Angiotensin-(1-7), adipokines and inflammation',
'volume': '95',
'author': 'Lelis',
'year': '2019',
'journal-title': 'Metabolism'},
{ 'key': 'ref_102',
'doi-asserted-by': 'crossref',
'first-page': '586',
'DOI': '10.1007/s00134-020-05985-9',
'article-title': 'Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: '
'Molecular mechanisms and potential therapeutic target',
'volume': '46',
'author': 'Zhang',
'year': '2020',
'journal-title': 'Intensive Care Med.'},
{ 'key': 'ref_103',
'doi-asserted-by': 'crossref',
'first-page': '59',
'DOI': '10.1016/j.bbi.2020.04.046',
'article-title': 'Current status of potential therapeutic candidates for the COVID-19 '
'crisis',
'volume': '87',
'author': 'Zhang',
'year': '2020',
'journal-title': 'Brain Behav. Immun.'},
{ 'key': 'ref_104',
'doi-asserted-by': 'crossref',
'first-page': '965',
'DOI': '10.1128/MCB.26.3.965-975.2006',
'article-title': 'Phenotypic analysis of mice lacking the TMPRSS2-encoded protease',
'volume': '26',
'author': 'Kim',
'year': '2006',
'journal-title': 'Mol. Cell Biol.'},
{ 'key': 'ref_105',
'doi-asserted-by': 'crossref',
'first-page': '779',
'DOI': '10.1158/2159-8290.CD-20-0451',
'article-title': 'TMPRSS2 and COVID-19: Serendipity or opportunity for intervention?',
'volume': '10',
'author': 'Stopsack',
'year': '2020',
'journal-title': 'Cancer Discov.'},
{ 'key': 'ref_106',
'doi-asserted-by': 'crossref',
'first-page': 'e202000786',
'DOI': '10.26508/lsa.202000786',
'article-title': 'TMPRSS2 and furin are both essential for proteolytic activation of '
'SARS-CoV-2 in human airway cells',
'volume': '3',
'author': 'Bestle',
'year': '2020',
'journal-title': 'Life Sci. Alliance'},
{ 'key': 'ref_107',
'doi-asserted-by': 'crossref',
'first-page': '100849',
'DOI': '10.1016/j.eclinm.2021.100849',
'article-title': 'Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients '
'hospitalized with COVID-19- A double-blind randomized controlled trial',
'volume': '35',
'author': 'Gunst',
'year': '2021',
'journal-title': 'EClinicalMedicine'},
{ 'key': 'ref_108',
'doi-asserted-by': 'crossref',
'first-page': '340',
'DOI': '10.1038/s41586-022-04661-w',
'article-title': 'A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and '
'therapeutic',
'volume': '605',
'author': 'Shapira',
'year': '2022',
'journal-title': 'Nature'},
{ 'key': 'ref_109',
'doi-asserted-by': 'crossref',
'first-page': 'e2108728118',
'DOI': '10.1073/pnas.2108728118',
'article-title': 'A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and '
'MERS-CoV viral entry and protect human epithelial lung cells',
'volume': '118',
'author': 'Mahoney',
'year': '2021',
'journal-title': 'Proc. Natl. Acad. Sci. USA'},
{ 'key': 'ref_110',
'doi-asserted-by': 'crossref',
'unstructured': 'Rahman, N., Basharat, Z., Yousuf, M., Castaldo, G., Rastrelli, L., and '
'Khan, H. (2020). Virtual screening of natural products against Type II '
'transmembrane serine protease (TMPRSS2), the priming agent of '
'coronavirus 2 (SARS-CoV-2). Molecules, 25.',
'DOI': '10.3390/molecules25102271'},
{ 'key': 'ref_111',
'doi-asserted-by': 'crossref',
'first-page': '725528',
'DOI': '10.3389/fmolb.2021.725528',
'article-title': 'Host serine proteases: A potential targeted therapy for COVID-19 and '
'influenza',
'volume': '8',
'author': 'Ardalan',
'year': '2021',
'journal-title': 'Front. Mol. Biosci.'},
{ 'key': 'ref_112',
'doi-asserted-by': 'crossref',
'first-page': '1124',
'DOI': '10.1021/acsptsci.0c00221',
'article-title': 'Discovery of TMPRSS2 inhibitors from virtual screening as a potential '
'treatment of COVID-19',
'volume': '4',
'author': 'Hu',
'year': '2021',
'journal-title': 'ACS Pharmacol. Transl. Sci.'},
{ 'key': 'ref_113',
'doi-asserted-by': 'crossref',
'first-page': '100870',
'DOI': '10.1016/j.imu.2022.100870',
'article-title': 'Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico '
'fragment-based drug design, molecular docking, molecular dynamics, and '
'quantum mechanics studies',
'volume': '29',
'author': 'Alzain',
'year': '2022',
'journal-title': 'Inform. Med. Unlocked'},
{ 'key': 'ref_114',
'doi-asserted-by': 'crossref',
'unstructured': 'Mahgoub, M.A., Alnaem, A., Fadlelmola, M., Abo-Idris, M., Makki, A.A., '
'Abdelgadir, A.A., and Alzain, A.A. (2022). Discovery of novel potential '
'inhibitors of TMPRSS2 and Mpro of SARS-CoV-2 using E-pharmacophore and '
'docking-based virtual screening combined with molecular dynamic and '
'quantum mechanics. J. Biomol. Struct. Dyn., 1–14.',
'DOI': '10.1080/07391102.2022.2112080'},
{ 'key': 'ref_115',
'doi-asserted-by': 'crossref',
'first-page': '1609',
'DOI': '10.1007/s11224-022-01991-3',
'article-title': 'Identification, virtual screening and molecular dynamic analysis of '
'novel TMPRSS2 inhibitors from natural compound database as potential '
'entry-blocking agents in SARS-CoV-2 therapy',
'volume': '33',
'author': 'Manandhar',
'year': '2022',
'journal-title': 'Struct. Chem.'},
{ 'key': 'ref_116',
'doi-asserted-by': 'crossref',
'first-page': 'e0284',
'DOI': '10.1097/CCE.0000000000000284',
'article-title': 'Camostat mesylate may reduce severity of coronavirus disease 2019 '
'sepsis: A first observation',
'volume': '2',
'author': 'Moerer',
'year': '2020',
'journal-title': 'Crit. Care Explor.'},
{ 'key': 'ref_117',
'doi-asserted-by': 'crossref',
'first-page': '392',
'DOI': '10.1186/s13054-020-03078-z',
'article-title': 'Nafamostat mesylate treatment in combination with favipiravir for '
'patients critically ill with COVID-19: A case series',
'volume': '24',
'author': 'Doi',
'year': '2020',
'journal-title': 'Crit. Care'},
{ 'key': 'ref_118',
'doi-asserted-by': 'crossref',
'first-page': '500',
'DOI': '10.1016/j.ijid.2020.05.072',
'article-title': 'Three cases of treatment with nafamostat in elderly patients with '
'COVID-19 pneumonia who need oxygen therapy',
'volume': '96',
'author': 'Jang',
'year': '2020',
'journal-title': 'Int. J. Infect. Dis.'},
{ 'key': 'ref_119',
'doi-asserted-by': 'crossref',
'first-page': '1161',
'DOI': '10.1038/s41564-022-01143-7',
'article-title': 'SARS-CoV-2 Omicron is an immune escape variant with an altered cell '
'entry pathway',
'volume': '7',
'author': 'Willett',
'year': '2022',
'journal-title': 'Nat. Microbiol.'},
{ 'key': 'ref_120',
'doi-asserted-by': 'crossref',
'first-page': '144',
'DOI': '10.1038/s41577-022-00681-9',
'article-title': 'Omicron entry route',
'volume': '22',
'author': 'Pia',
'year': '2022',
'journal-title': 'Nat. Rev. Immunol.'},
{ 'key': 'ref_121',
'doi-asserted-by': 'crossref',
'unstructured': 'Peacock, T.P., Brown, J.C., Zhou, J., Thakur, N., Sukhova, K., Newman, '
'J., Kugathasan, R., Yan, A.W.C., Furnon, W., and Lorenzo, G.D. (2021). '
'The altered entry pathway and antigenic distance of the SARS-CoV-2 '
'Omicron variant map to separate domains of spike protein. bioRxiv.',
'DOI': '10.1101/2021.12.31.474653'},
{ 'key': 'ref_122',
'doi-asserted-by': 'crossref',
'first-page': '649',
'DOI': '10.1038/s41443-021-00524-6',
'article-title': 'Androgens and COVID-19: Exploring the role of testosterone replacement '
'therapy',
'volume': '34',
'author': 'Punjani',
'year': '2022',
'journal-title': 'Int. J. Impot. Res.'},
{ 'key': 'ref_123',
'first-page': '45',
'article-title': 'The role of androgen receptor mutations in progression of prostate '
'cancer',
'volume': 'Volume 1',
'author': 'Neri',
'year': '2013',
'journal-title': 'Advances in Genome Science, Changing Views on Living Organisms'},
{ 'key': 'ref_124',
'doi-asserted-by': 'crossref',
'first-page': '18',
'DOI': '10.2174/138920209787581307',
'article-title': 'The role of androgen receptor mutations in prostate cancer progression',
'volume': '10',
'author': 'Brooke',
'year': '2009',
'journal-title': 'Current Genom.'},
{ 'key': 'ref_125',
'doi-asserted-by': 'crossref',
'first-page': '594',
'DOI': '10.3389/fendo.2018.00594',
'article-title': 'The divergent function of androgen receptor in breast cancer; analysis '
'of steroid mediators and tumor intracrinology',
'volume': '9',
'author': 'Bleach',
'year': '2018',
'journal-title': 'Front. Endocrinol.'},
{ 'key': 'ref_126',
'doi-asserted-by': 'crossref',
'first-page': '858',
'DOI': '10.3389/fonc.2019.00858',
'article-title': 'Androgen receptor signaling in the development of castration-resistant '
'prostate cancer',
'volume': '9',
'author': 'Feng',
'year': '2019',
'journal-title': 'Front. Oncol.'},
{ 'key': 'ref_127',
'doi-asserted-by': 'crossref',
'unstructured': 'Dart, D.A., Waxman, J., Aboagye, E.O., and Bevan, C.L. (2013). '
'Visualising androgen receptor activity in male and female mice. PLoS '
'ONE, 8.',
'DOI': '10.1371/journal.pone.0071694'},
{ 'key': 'ref_128',
'doi-asserted-by': 'crossref',
'first-page': '14',
'DOI': '10.1016/j.mce.2009.12.022',
'article-title': 'Androgen receptor and androgen-dependent gene expression in lung',
'volume': '317',
'author': 'Mikkonen',
'year': '2010',
'journal-title': 'Mol. Cell Endocrinol.'},
{ 'key': 'ref_129',
'doi-asserted-by': 'crossref',
'first-page': '11130',
'DOI': '10.1038/s41598-021-90491-1',
'article-title': 'Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications '
'for sex-discordant COVID-19 outcomes',
'volume': '11',
'author': 'Baratchian',
'year': '2021',
'journal-title': 'Sci. Rep.'},
{ 'key': 'ref_130',
'doi-asserted-by': 'crossref',
'first-page': '4068',
'DOI': '10.1038/s41467-021-24342-y',
'article-title': 'The antiandrogen enzalutamide downregulates TMPRSS2 and reduces '
'cellular entry of SARS-CoV-2 in human lung cells',
'volume': '12',
'author': 'Leach',
'year': '2021',
'journal-title': 'Nat. Commun.'},
{ 'key': 'ref_131',
'doi-asserted-by': 'crossref',
'first-page': 'bvac047',
'DOI': '10.1210/jendso/bvac047',
'article-title': 'Association Between Asthma and Reduced Androgen Receptor Expression in '
'Airways',
'volume': '6',
'author': 'McManus',
'year': '2022',
'journal-title': 'J. Endocr. Soc.'},
{ 'key': 'ref_132',
'doi-asserted-by': 'crossref',
'first-page': '1012',
'DOI': '10.1126/science.abb7314',
'article-title': 'Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman '
'primate model',
'volume': '368',
'author': 'Rockx',
'year': '2020',
'journal-title': 'Science'},
{ 'key': 'ref_133',
'doi-asserted-by': 'crossref',
'first-page': '2028',
'DOI': '10.1210/me.2013-1098',
'article-title': 'Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an '
'androgen response element',
'volume': '27',
'author': 'Clinckemalie',
'year': '2013',
'journal-title': 'Mol. Endocrinol.'},
{ 'key': 'ref_134',
'doi-asserted-by': 'crossref',
'first-page': '866',
'DOI': '10.1038/s41467-021-21171-x',
'article-title': 'Distinct mechanisms for TMPRSS2 expression explain organ-specific '
'inhibition of SARS-CoV-2 infection by enzalutamide',
'volume': '12',
'author': 'Li',
'year': '2021',
'journal-title': 'Nat. Commun.'},
{ 'key': 'ref_135',
'unstructured': '(2022, November 01). Science. Wadman, M. Why Coronavirus Hits Men '
'Harder: Sex Hormones Offer Clues. Available online: '
'https://www.science.org/content/article/why-coronavirus-hits-men-harder-sex-hormones-offer-clues.'},
{ 'key': 'ref_136',
'doi-asserted-by': 'crossref',
'first-page': 'bqab114',
'DOI': '10.1210/endocr/bqab114',
'article-title': 'Do anti-androgens have potential as therapeutics for COVID-19?',
'volume': '162',
'year': '2021',
'journal-title': 'Endocrinology'},
{ 'key': 'ref_137',
'doi-asserted-by': 'crossref',
'first-page': '261',
'DOI': '10.1586/17469872.1.2.261',
'article-title': 'Antiandrogen therapy for androgenetic alopecia',
'volume': '1',
'author': 'Yip',
'year': '2014',
'journal-title': 'Expert Rev. Dermatol.'},
{ 'key': 'ref_138',
'doi-asserted-by': 'crossref',
'first-page': 'S362',
'DOI': '10.21037/atm.2019.09.53',
'article-title': 'The importance of antiandrogen in prostate cancer treatment',
'volume': '7',
'author': 'Lanz',
'year': '2019',
'journal-title': 'Ann. Transl. Med.'},
{ 'key': 'ref_139',
'doi-asserted-by': 'crossref',
'first-page': '1413',
'DOI': '10.1634/theoncologist.2011-0164',
'article-title': 'Revisiting the role of antiandrogen strategies in ovarian cancer',
'volume': '16',
'author': 'Dedes',
'year': '2011',
'journal-title': 'Oncologist'},
{ 'key': 'ref_140',
'doi-asserted-by': 'crossref',
'first-page': 'R257',
'DOI': '10.1530/JME-14-0030',
'article-title': 'Revising the role of the androgen receptor in breast cancer',
'volume': '52',
'author': 'Fioretti',
'year': '2014',
'journal-title': 'J. Mol. Endocrinol.'},
{ 'key': 'ref_141',
'doi-asserted-by': 'crossref',
'unstructured': 'Anestis, A., Zoi, I., Papavassiliou, A.G., and Karamouzis, M.V. (2020). '
'Androgen receptor in breast cancer-clinical and preclinical research '
'insights. Molecules, 25.',
'DOI': '10.3390/molecules25020358'},
{ 'key': 'ref_142',
'doi-asserted-by': 'crossref',
'first-page': '91',
'DOI': '10.1586/eem.11.85',
'article-title': 'Androgens and polycystic ovary syndrome',
'volume': '7',
'author': 'Alpanes',
'year': '2012',
'journal-title': 'Expert Rev. Endocrinol. Metab.'},
{ 'key': 'ref_143',
'doi-asserted-by': 'crossref',
'first-page': '102254',
'DOI': '10.1016/j.isci.2021.102254',
'article-title': 'Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic '
'strategy to combat COVID-19',
'volume': '24',
'author': 'Deng',
'year': '2021',
'journal-title': 'iScience'},
{ 'key': 'ref_144',
'doi-asserted-by': 'crossref',
'first-page': '1040',
'DOI': '10.1016/j.annonc.2020.04.479',
'article-title': 'Androgen-deprivation therapies for prostate cancer and risk of '
'infection by SARS-CoV-2: A population-based study (N = 4532)',
'volume': '31',
'author': 'Montopoli',
'year': '2020',
'journal-title': 'Ann. Oncol.'},
{ 'key': 'ref_145',
'doi-asserted-by': 'crossref',
'first-page': '1419',
'DOI': '10.1016/j.annonc.2020.06.023',
'article-title': 'Does androgen deprivation therapy protect against severe complications '
'from COVID-19?',
'volume': '31',
'author': 'Patel',
'year': '2020',
'journal-title': 'Ann. Oncol.'},
{ 'key': 'ref_146',
'doi-asserted-by': 'crossref',
'first-page': '774773',
'DOI': '10.3389/fmed.2022.774773',
'article-title': 'A population-level analysis of the protective effects of androgen '
'deprivation therapy against COVID-19 disease incidence and severity',
'volume': '9',
'author': 'Lee',
'year': '2022',
'journal-title': 'Front. Med.'},
{ 'key': 'ref_147',
'doi-asserted-by': 'crossref',
'first-page': 'e243',
'DOI': '10.1111/jdv.17021',
'article-title': '5-alpha-reductase inhibitors are associated with reduced frequency of '
'COVID-19 symptoms in males with androgenetic alopecia',
'volume': '35',
'author': 'McCoy',
'year': '2021',
'journal-title': 'J. Eur. Acad. Dermatol. Venereol.'},
{ 'key': 'ref_148',
'doi-asserted-by': 'crossref',
'first-page': '285',
'DOI': '10.1016/j.eururo.2021.12.013',
'article-title': 'A Phase 2 Trial of the effect of antiandrogen therapy on COVID-19 '
'outcome: No evidence of benefit, supported by epidemiology and in vitro '
'data',
'volume': '81',
'author': 'Welen',
'year': '2022',
'journal-title': 'Eur. Urol.'},
{ 'key': 'ref_149',
'doi-asserted-by': 'crossref',
'first-page': 'e227852',
'DOI': '10.1001/jamanetworkopen.2022.7852',
'article-title': 'Effect of androgen suppression on clinical outcomes in hospitalized men '
'with COVID-19: The HITCH randomized clinical trial',
'volume': '5',
'author': 'Nickols',
'year': '2022',
'journal-title': 'JAMA Netw. Open'},
{ 'key': 'ref_150',
'doi-asserted-by': 'crossref',
'first-page': '2905',
'DOI': '10.1021/jacs.1c08402',
'article-title': 'Ultralarge virtual screening identifies SARS-CoV-2 main protease '
'inhibitors with broad-spectrum activity against coronaviruses',
'volume': '144',
'author': 'Luttens',
'year': '2022',
'journal-title': 'J. Am. Chem. Soc.'},
{ 'key': 'ref_151',
'doi-asserted-by': 'crossref',
'first-page': '1373',
'DOI': '10.1002/jmv.27517',
'article-title': 'Broad-spectrum prodrugs with anti-SARS-CoV-2 activities: Strategies, '
'benefits, and challenges',
'volume': '94',
'author': 'Wang',
'year': '2022',
'journal-title': 'J. Med. Virol.'}],
'container-title': 'Viruses',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.mdpi.com/1999-4915/14/12/2728/pdf',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2022, 12, 7]],
'date-time': '2022-12-07T07:57:49Z',
'timestamp': 1670399869000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.mdpi.com/1999-4915/14/12/2728'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2022, 12, 7]]},
'references-count': 151,
'journal-issue': {'issue': '12', 'published-online': {'date-parts': [[2022, 12]]}},
'alternative-id': ['v14122728'],
'URL': 'http://dx.doi.org/10.3390/v14122728',
'relation': { 'has-preprint': [ { 'id-type': 'doi',
'id': '10.20944/preprints202211.0075.v1',
'asserted-by': 'object'}]},
'ISSN': ['1999-4915'],
'subject': [],
'container-title-short': 'Viruses',
'published': {'date-parts': [[2022, 12, 7]]}}
